Physician-related barriers to cancer pain management with opioid analgesics: A systematic review

Ramune Jacobsen, MS, MPH; Per Sjøgren, MD, DMS; Claus Møldrup, PhD; Lona Christrup, PhD

doi:10.5055/jom.2007.0006

Authors

Ramune Jacobsen, MS, MPH
Per Sjøgren, MD, DMS
Claus Møldrup, PhD
Lona Christrup, PhD

DOI:

https://doi.org/10.5055/jom.2007.0006

Keywords:

cancer pain, opioid prescription, physicians, barriers

Abstract

Objective: The purpose of this review is to summarize the results of studies on physician-related barriers to cancer pain management with opioid analgesics.
Methods: A literature search was conducted in PUBMED, using a combined text word and MeSH heading search strategy. Those articles whose full texts were not available in PUBMED were retrieved from the electronic databases of specific journals.
Results: Sixty-five relevant articles, published in the period from 1986 to 2006, were identified. Physicians’ barriers to cancer pain management were studied in questionnaire surveys and in the reviews of drug prescribing documents. The results of the articles found were analyzed with respect to (a) knowledge, beliefs, concerns, problems endorsed or acknowledged by physicians treating cancer pain, (b) physicians’ skills in pain assessment, and (c) adequacy of opioid prescription.
Conclusions: This review revealed mostly general and common physician-related barriers to cancer pain management: concerns about side effects to opioids, prescription of not efficient doses of opioids, and very poor prescription for the treatment of side effects from opioids. In the future, the evaluation of the influence of cultural-social-economical background, as well as the differences between the various specialists involved in the care of patients with cancer, should be explored to better understand physicians’ barriers and more effectively address them in interventional and educational programs.

Author Biographies

Ramune Jacobsen, MS, MPH

Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark.

Per Sjøgren, MD, DMS

The Multidisciplinary Pain Center, Danish National Hospital, Copenhagen, Denmark.

Claus Møldrup, PhD

Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark.

Lona Christrup, PhD

Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark.

References

Cherny NI: The assessment of cancer pain. In McMillan SC, Koltzenburg M (eds.): Wall and Melzack’s Textbook of Pain. London: Elsevier, 2006: 1099-1125.

Syrjala KO, Cleeland CS: How to assess cancer pain. In Turk DC, Melzack R (eds.): Handbook of Pain Assessment. New York: The Guilford Press, 2001: 579-600.

Grond S, Radbruch L, Meuser T, et al.: Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999; 79(1): 15-20.

Meuser T, Pietruck C, Radbruch L, et al.: Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001; 93(3): 247-257.

Zech DF, Grond S, Lynch J, et al.: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain. 1995; 63(1): 65-76.

Cleeland CS: Barriers to the management of cancer pain. Oncology (Williston Park). 1987; 1(2 suppl): 19-26.

Payne R: Chronic pain: Challenges in the assessment and management of cancer pain. J Pain Symptom Manage. 2000; 19(1 suppl): S12-S15.

Hill CS Jr: The barriers to adequate pain management with opioid analgesics. Semin Oncol. 1993; 20(2 suppl 1): 1-5.

Allard P, Maunsell E, Labbe J, et al.: Educational interventions to improve cancer pain control: A systematic review. J Palliat Med. 2001; 4(2): 191-203.

Alvarez MP, Agra Y: Systematic review of educational interventions in palliative care for primary care physicians. Palliat Med. 2006; 20(7): 673-683.

Ajzen I: The theory of planned behavior. Organ Behav Hum Decis Process. 1991; 50: 179-211.

World Health Organization Technical Report Series. Cancer Pain Relief and Palliative Care (804). Geneva: WHO, 1990.

Jacox A, Carr DB, Payne R: Management of Cancer Pain: Adults. Clinical Practice Guideline No. 9. (no. 94-0592). Rockville, MD: US Dept of Health & Human Services, Public Health Service, 1994.

Mercadante S: Opioid prescription in Italy: New law, no effect. Lancet. 2002; 360(9341): 1254-1255.

Sorge J, Luders B, Werry C, et al.: Supply of opioid analgesics to outpatients with cancer pain. Schmerz. 1996; 10(6): 283-291.

Weissman DE, Joranson DE, Hopwood MB: Wisconsin physicians’ knowledge and attitudes about opioid analgesic regulations. Wis Med J. 1991; 90(12): 671-675.

Wikipedia, the free encyclopedia. Available at http://en.wikipedia.org/wiki/Belief. Assessed July 2, 2007.

Wikipedia, the free encyclopedia. Available at http://en.wikipedia.org/wiki/Knowledge. Assessed July 2, 2007.

Ensink FB, Bautz MT, Voss MC, et al.: Indicators of structural quality in palliative care for cancer pain patients in Lower- Saxony. Schmerz. 2002; 16(4): 255-262.

Kaasalainen V, Vainio A, li-Melkkila T: Developments in the treatment of cancer pain in Finland: The third nation-wide survey. Pain. 1997; 70(2/3): 175-183.

Lopez de MA, Morago V, San EE, et al.: Attitudes of general practitioners in Bizkaia, Spain, towards the terminally ill patient. Palliat Med. 1993; 7(1): 39-45.

Mystakidou K, Liossi C, Fragiadakis K, et al.: What do Greek physicians know about managing cancer pain? J Cancer Educ. 1998; 13(1): 39-42.

Warncke T, Breivik H, Vainio A: Treatment of cancer pain in Norway. A questionnaire study. Pain. 1994; 57(1): 109-116.

Weinstein SM, Laux LF, Thornby JI, et al.: Physicians’ attitudes toward pain and the use of opioid analgesics: Results of a survey from the Texas Cancer Pain Initiative. South Med J. 2000; 93(5): 479-487.

Minotti V, Betti M: Attitudes of Italian general practitioners in the treatment of cancer pain. The Committee of the Associazione Italiana di Oncologia Medica (AIOM). Tumori. 1997; 83(4): 729-731.

Rawal N, Hylander J, Arner S: Management of terminal cancer pain in Sweden: a nationwide survey. Pain. 1993; 54(2): 169-179.

Sabatowski R, Arens ER, Waap I, et al.: Cancer pain management in Germany–Results and analysis of a questionnaire. Schmerz. 2001; 15(4): 241-247.

White ID, Hoskin PJ, Hanks GW, et al.: Analgesics in cancer pain: Current practice and beliefs. Br J Cancer. 1991; 63(2): 271-274.

MacDonald N, Findlay HP, Bruera E, et al.: A Canadian survey of issues in cancer pain management. J Pain Symptom Manage. 1997; 14(6): 332-342.

Sapir R, Catane R, Strauss-Liviatan N, et al.: Cancer pain: Knowledge and attitudes of physicians in Israel. J Pain Symptom Manage. 1999; 17(4): 266-276.

Yu S, Wang XS, Cheng Y, et al.: Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain. 2001; 5(suppl A): 15-20.

Vainio A: Treatment of terminal cancer pain in France: A questionnaire study. Pain. 1995; 62(2): 155-162.

Anderson KO, Mendoza TR, Valero V, et al.: Minority cancer patients and their providers: Pain management attitudes and practice. Cancer. 2000; 88(8): 1929-1938.

Elliott TE, Elliott BA: Physician attitudes and beliefs about use of morphine for cancer pain. J Pain Symptom Manage. 1992; 7(3): 141-148.

Furstenberg CT, Ahles TA, Whedon MB, et al.: Knowledge and attitudes of health-care providers toward cancer pain management: A comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage. 1998; 15(6): 335-349.

Gallagher R, Hawley P, Yeomans W: A survey of cancer pain management knowledge and attitudes of British Columbian physicians. Pain Res Manag. 2004; 9(4): 188-194.

Greenwald BD, Narcessian EJ, Pomeranz BA: Assessment of physiatrists’ knowledge and perspectives on the use of opioids: Review of basic concepts for managing chronic pain. Am J Phys Med Rehabil. 1999; 78(5): 408-415.

Mortimer JE, Bartlett NL: Assessment of knowledge about cancer pain management by physicians in training. J Pain Symptom Manage. 1997; 14(1): 21-28.

Rothstein D, Strumpf M, Dertwinkel R, et al.: A survey of physicians’ knowledge about pain therapy with strong opioid analgesics. Schmerz. 1998; 12(2): 125-129.

Vainio A: Practising physicians’ experiences of treating patients with cancer pain. Acta Oncol. 1989; 28(2): 177-182.

Wu HB, Lee MC, Lai KH, et al.: Physicians’ knowledge about pharmacological management of cancer pain–With special reference on their prescribing responses to simulated patients with cancer pain. Acta Anaesthesiol Taiwan. 2006; 44(2): 61-71.

Welsh J, Reid A, Graham J, et al.: Physicians’ knowledge of transdermal fentanyl. Palliat Med. 2005; 19(1): 9-16.

MacDonald N, Ayoub J, Farley J, et al.: A Quebec survey of issues in cancer pain management. J Pain Symptom Manage. 2002; 23(1): 39-47.

Morley-Forster PK, Clark AJ, Speechley M, et al.: Attitudes toward opioid use for chronic pain: A Canadian physician survey. Pain Res Manag. 2003; 8(4): 189-194.

Ger LP, Ho ST, Wang JJ: Physicians’ knowledge and attitudes toward the use of analgesics for cancer pain management: A survey of two medical centers in Taiwan. J Pain Symptom Manage. 2000; 20(5): 335-344.

Larue F, Colleau SM, Fontaine A, et al.: Oncologists and primary care physicians’ attitudes toward pain control and morphine prescribing in France. Cancer. 1995; 76(11): 2375-2382.

Salvato C, Aretini G, Serraglia D, et al.: Opioid prescription for terminally ill outpatients in a district of northern Italy: A retrospective survey. Pharmacol Res. 2003; 48(1): 75-82.

Tzeitlin T, Shvartzman P: Knowledge, attitudes and skills of family physicians in Israel with regard to chronic pain management in cancer. Harefuah. 2000; 139(7/8): 252-255, 328.

Von Roenn JH, Cleeland CS, Gonin R, et al.: Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993; 119(2): 121-126.

Stiefel F, Morant R, Radziwill A, et al.: Attitudes of Swiss physicians in prescribing opiates for cancer pain. Support Care Cancer. 1993; 1(5): 259-262.

Stiefel F, Radziwill A, Morant R, et al.: Chronic tumor pain and opiates: A survey of prescription practice among physicians of German-speaking Switzerland. Schweiz Rundsch Med Prax. 1993; 82(10): 283-288.

Bhamb B, Brown D, Hariharan J, et al.: Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006; 22(9): 1859-1865.

Devi BC, Tang TS, Corbex M: What doctors know about cancer pain management: An exploratory study in Sarawak, Malaysia. J Pain Palliat Care Pharmacother. 2006; 20(2): 15-22.

Ger LP, Lee MC, Wong CS, et al.: The effect of education and clinical practice on knowledge enlightenment to and attitudes toward the use of analgesics for cancer pain among physicians and medical students. Acta Anaesthesiol Sin. 2003; 41(3): 105-114.

Elliott TE, Murray DM, Elliott BA, et al.: Physician knowledge and attitudes about cancer pain management: A survey from the Minnesota cancer pain project. J Pain Symptom Manage. 1995; 10(7): 494-504.

Cleeland CS, Janjan NA, Scott CB, et al.: Cancer pain management by radiotherapists: A survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys. 2000; 47(1): 203-208.

Mercadante S, Salvaggio L: Cancer pain knowledge in Southern Italy: Data from a postgraduate refresher course. J Pain Symptom Manage. 1996; 11(2): 108-115.

Sjogren P, Banning AM, Jensen NH, et al.: Management of cancer pain in Denmark: A nationwide questionnaire survey. Pain. 1996; 64(3): 519-525.

Ponte CD, Johnson-Tribino J: Attitudes and knowledge about pain: An assessment of West Virginia family physicians. Fam Med. 2005; 37(7): 477-480.

Zenz M, Zenz T, Tryba M, et al.: Severe undertreatment of cancer pain: A 3-year survey of the German situation. J Pain Symptom Manage. 1995; 10(3): 187-191.

Porzio G, Valenti M, Aielli F, et al.: Assessment and treatment of symptoms among Italian medical oncologists. Support Care Cancer. 2005; 13(11): 865-869.

Soyannwo A, manor-Boadu SD: Management of cancer pain–A survey of current practice in West Africa. Niger Postgrad Med J. 2001; 8(4): 175-178.

Ben Diane MK, Peretti-Watel P, Galinier A, et al.: Morphine prescription to terminal cancer patients suffering from severe pain: Results of a French survey. Bull Cancer (Paris). 2005; 92(7): 733-740.

Trollor J: Cancer inpatients morphine usage: A new England area survey. Aust J Rural Health. 2003; 11(4): 163-168.

Javier FO, Magpantay LA, Espinosa EL, et al.: Opioid use in chronic pain management in the Philippines. Eur J Pain. 2001; 5(suppl A): 83-85.

Barclay S, Todd C, Grande G, et al.: Controlling cancer pain in primary care: The prescribing habits and knowledge base of general practitioners. J Pain Symptom Manage. 2002; 23(5): 383-392.

Kotani K: Morphine use for at-home cancer patients in Japan. Tohoku J Exp Med. 2004; 204(2): 119-123.

Jensen NH, Banning AM, Jensen MB, et al.: Treatment of cancer pain in Denmark. A questionnaire survey. Ugeskr Laeger. 1997; 159(14): 2086-2090.

Yun YH, Park SM, Lee K, et al.: Predictors of prescription of morphine for severe cancer pain by physicians in Korea. Ann Oncol. 2005; 16(6): 966-971.

Vainio A: Treatment of terminal cancer pain in Finland. A questionnaire survey. Acta Anaesthesiol Scand. 1988; 32(3): 260-265.

Vainio A: Treatment of terminal cancer pain in Finland: A second look. Acta Anaesthesiol Scand. 1992; 36(1): 89-95.

Ben Diane MK, Pegliasco H, Galinier A, et al.: Terminal care of patients by the general practitioner and the specialist. Results of a French survey “Attitudes and practices in palliative treatment– 2002.” Presse Med. 2003; 32(11): 488-492.

Cleeland CS, Cleeland LM, Dar R, et al.: Factors influencing physician management of cancer pain. Cancer. 1986; 58(3): 796-800.

Jenkins BG, Tuffin PH, Choo CL, et al.: Opioid prescribing: An assessment using quality statements. J Clin Pharm Ther. 2005; 30(6): 597-602.

Lawrie I, Lloyd-Williams M, Waterhouse E: Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice. Am J Hosp Palliat Care. 2003; 20(3): 229-230.

Neo SH, Loh EC, Koo WH: An audit of morphine prescribing in a hospice. Singapore Med J. 2001; 42(9): 417-419.

Llanes LR, Fassbender K, Baracos VE, et al.: Drug utilization review on a tertiary palliative care unit. J Pain Symptom Manage. 2006; 31(5): 457-464.

Ripamonti C, Fagnoni E, Campa T, et al.: Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy. Support Care Cancer. 2006; 14(5): 400-407.

Lindena G, Muller S: The prescription of opioids from the point of view of clinical and market research. Schmerz. 1996; 10(6): 319-325.

Weber M, Huber C: Documentation of severe pain, opioid doses, and opioid-related side effects in outpatients with cancer: a retrospective study. J Pain Symptom Manage. 1999; 17(1): 49-54.

Haines CS, Thomas Z: Assessing needs for palliative care education of primary care physicians: results of a mail survey. J Palliat Care. 1993; 9(1): 23-26.

Jubelirer SJ, Warren CS, Rector R, et al.: Attitudes about cancer pain: A survey of 727 health care professionals in West Virginia. W V Med J. 1998; 94(4): 192-194.

Peretti-Watel P, Bendiane MK, Obadia Y, et al.: The prescription of opioid analgesics to terminal cancer patients: impact of physicians’ general attitudes and contextual factors. Palliat Support Care. 2003; 1(4): 345-352.

Hemminki E: Factors influencing prescribing. In Ghodse AH, Khan I (eds.): Psychoactive Drugs: Improving Prescribing Practices. Geneva: World Health Organization, 1988: 22-32.